跳至主要内容
临床试验/NCT05069350
NCT05069350已完成早期 1 期

A Double Blinded Randomized Controlled Study of Topical Anaesthetics Oxybuprocaine Versus Bupivacaine 0.5% in Intravitreal Injections

Research Institute of Ophthalmology, Egypt1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
100
试验地点
1
主要终点
verbal pain numerical scaling

研究概览

简要总结

comparing two local anaesthetic agents, Bupivacaine 0.5% versus Oxybuprocaine used topically to provide surface anaesthesia before IVI procedures.

详细描述

In preparation zone, we will cannulate the patients, connect them to the pulse oximetry and we will start providing appropriate surface anaesthesia for an adequate period of time before the patient administration of the injection, by applying the anaesthetic agents, 3 times with 5 minutes interval, for 15 minutes and then waitng the injection

All patients are informed that they are going to receive topical anaesthetic agent before the IVI.

pain is monitored during the injection by using the 11 points verbal numerical pain scaling as zero is for no pain and 10 is for severe unbearable pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients between 30 to 70 years

排除标准

  • uncooperative patients

研究组 & 干预措施

bupivacaine 0.5%

Experimental

干预措施: bupivacaine 0.5% and oxubuprocaine (Drug)

oxybuprocaine

Experimental

干预措施: bupivacaine 0.5% and oxubuprocaine (Drug)

结局指标

主要结局

verbal pain numerical scaling

时间窗: 10 minutes

11 point scale from 0-10 zero measns No pain 10 means severe unbearable pain

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验